The global CAR T-cell therapy market is experiencing significant growth, fueled by increasing acceptance of this innovative approach for a range of malignancies. Key factors shaping the market include increasing prevalence of cancer, advancements in science, and supportive regulations. The market is characterized by a dynamic landscape with severa